infoscythianhealthcare

Problems with Eyes, Skin, Nervous System, Or Period Issues: New Study Found Covaxin Side Effects after 1-year Follow-up

Problems with Eyes, Skin, Nervous System, Or Period Issues: New Study Found Covaxin Side Effects after 1-year Follow-up If you are a female, a youngster with pre-vaccination Covid, a person with weak health, or you had a bout of typhoid just after having your coronavirus vaccine, your chances of showing a side effect from Covaxin are higher […]

Problems with Eyes, Skin, Nervous System, Or Period Issues: New Study Found Covaxin Side Effects after 1-year Follow-up Read More »

A Recent Study Found Covaxin Effective Against Delta Plus Variant

A Recent Study Found Covaxin Effective Against Delta Plus Variant Covaxin, which is essentially a whole-virion inactivated SARS-CoV-2 vaccine, was found to be effective against the earlier Delta variant. Even during the second wave, which was mainly caused by the Delta variant, this vaccine proved to be 65.2% effective in protecting vaccinated people from the

A Recent Study Found Covaxin Effective Against Delta Plus Variant Read More »

Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD

Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD Nova Laboratories’ Xromi (hydroxycarbamide) has received approval from the Medicines and Healthcare products Regulatory Agency and the European Commission to extend the indication for vaso-occlusive complications of sickle cell disease (SCD) to infants from nine months of age. SCD is a group of

Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD Read More »

International phase 3 clinical trial for new melanoma treatment recruits first patients

International phase 3 clinical trial for new melanoma treatment recruits first patients A phase 3 international trial evaluating a new personalised immunotherapy treatment for melanoma has recruited its first patients at University College London Hospitals (UCLH) NHS Foundation Trust. Results from the phase 2 study evaluating Moderna and Merck & Co’s – known as MSD

International phase 3 clinical trial for new melanoma treatment recruits first patients Read More »

Cambridge researchers develop robotic nerve devices for neurological conditions

Cambridge researchers develop robotic nerve devices for neurological conditions Researchers at the University of Cambridge have developed small, flexible devices, combining electronics and soft robotics, to help treat a range of neurological conditions, including epilepsy and chronic pain. Published in Nature Materials, the nerve cuff implant has the ability to change shape through electrical activation,

Cambridge researchers develop robotic nerve devices for neurological conditions Read More »